Following a recent uproar,...Mylan NV (MYL) said Wednesday it would help reduce the cost of the emergency allergy drug for people who are struggling to afford it. In a press release, Mylan said it would provide instant savings cards...[that amount] to about a 50% price cut for people without insurance or for patients with high deductible plans...

When asked why the price of EpiPen increased so dramatically over the years, [Mylan CEO Heather Bresch]...blamed "the system" which needs to be "fixed."... But Sen. Richard Blumenthal, a Democrat from Connecticut, isn't convinced. "This step seems like a PR fix more than a real remedy, masking an exorbitant and callous price hike," he said. "This baby step should be followed by actual robust action."